News

Developed and manufactured by EDGE, the QuixFP-100 Flat Panel Digital Detector with Plasma DR™ Readout Technology provides a cost and performance advantage over Thin-Film Transistor (TFT) Active Matrix Array-based detectors; it does not require the costly and complex manufacturing process used to make TFTs. The detectors are permanently zero-defect, from installation through years of imaging, and offer a full pixel matrix with no dead lines, pixels or pixel clusters

The detector has regulatory approval and is packaged for OEMs, integrators and VARs as part of the Quix™ universal retrofit kit, which maximizes return on investment by enabling digital upgrades to any new or previously installed equipment. This streamlines installation and minimizes downtime during the transition from analog to digital.

According to EDGE Chairman of the Board, Dr. Uri Geiger, "With the financial backing of Israeli medical device investment firm, Accelmed, EDGE is well-positioned to bring digital radiography to hospitals, clinics and outpatient centers that have previously been unable to afford to upgrade."

"EDGE has fulfilled the promise of delivering a flat-panel medical imaging detector without the inherent cost and reliability drawbacks of active matrix array technologies. EDGE has invented a robust medical imaging platform that breaks through the cost barriers that have made DR unaffordable for the largest segment of the healthcare market," says Dr. Albert Zur, EDGE CEO and President.

About EDGE Medical Devices
EDGE Medical Devices (www.edge-medical.com) is the developer and manufacturer of Plasma DR™ flat-panel X-ray detector technology for digital radiography. Plasma DR™ offers a price/performance breakthrough by eliminating the complex active matrix array technology used for image readout in other flat-panel detectors. EDGE works with OEMs, Integrators and VARs to bring high quality digital radiography to all diagnostic imaging settings, from private imaging facilities to community hospitals to major medical centers.

About AccelMed
AccelMed (www.accelmed.com) is an investment firm focusing on established, Israel-based, late stage medical device companies with unique technologies, significant market potential and proven clinical data. Founded by Mori Arkin and Dr. Uri Geiger and led by a team of accomplished investment professionals with extensive experience in the medical and life science fields, Accelmed offers more than access to capital. It offers a collective experience and know-how in all aspects of the business: clinical, regulatory, IP, marketing and business development leading to the mutual goal of building a successful business.

For more information, contact:

Rochelle Nemrow
EDGE Medical Devices
Public Relations
877.387.3343 x104
rnemrow@EDGE-medical.com